920 related articles for article (PubMed ID: 10213546)
21. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study.
Ewertz M; Mellemkjaer L; Poulsen AH; Friis S; Sørensen HT; Pedersen L; McLaughlin JK; Olsen JH
Br J Cancer; 2005 Apr; 92(7):1293-7. PubMed ID: 15785751
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and breast cancer risk in California.
Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
[TBL] [Abstract][Full Text] [Related]
23. Hormone replacement therapy and breast cancer: revisiting the issues.
DeGregorio MW; Taras TL
J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
[TBL] [Abstract][Full Text] [Related]
24. Do women taking hormone replacement therapy (HRT) have a higher incidence of breast cancer than women who do not?
Fleming RM
Integr Cancer Ther; 2003 Sep; 2(3):235-7. PubMed ID: 15035886
[TBL] [Abstract][Full Text] [Related]
25. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 2002 Jul; 360(9328):187-95. PubMed ID: 12133652
[TBL] [Abstract][Full Text] [Related]
27. Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort.
Yoo TK; Han KD; Kim D; Ahn J; Park WC; Chae BJ
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1341-1347. PubMed ID: 32299849
[TBL] [Abstract][Full Text] [Related]
28. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
Reeves GK; Beral V; Green J; Gathani T; Bull D;
Lancet Oncol; 2006 Nov; 7(11):910-8. PubMed ID: 17081916
[TBL] [Abstract][Full Text] [Related]
29. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
[TBL] [Abstract][Full Text] [Related]
30. Systematic review about breast cancer incidence in relation to hormone replacement therapy use.
Antoine C; Ameye L; Paesmans M; Rozenberg S
Climacteric; 2014 Apr; 17(2):116-32. PubMed ID: 23909434
[TBL] [Abstract][Full Text] [Related]
31. [Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer].
Bonnier P; Sakr R; Bessenay F; Lejeune C; Charpin C; Martin PM; Piana L
Gynecol Obstet Fertil; 2000 Oct; 28(10):745-53. PubMed ID: 11244637
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.
Kotsopoulos J; Huzarski T; Gronwald J; Moller P; Lynch HT; Neuhausen SL; Senter L; Demsky R; Foulkes WD; Eng C; Karlan B; Tung N; Singer CF; Sun P; Lubinski J; Narod SA
Breast Cancer Res Treat; 2016 Jan; 155(2):365-73. PubMed ID: 26780555
[TBL] [Abstract][Full Text] [Related]
33. [Hormone replacement therapy and breast cancer].
Dobashi K
Gan To Kagaku Ryoho; 1999 Jun; 26(7):871-6. PubMed ID: 10396312
[TBL] [Abstract][Full Text] [Related]
34. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
36. Factors modifying the association between hormone-replacement therapy and breast cancer risk.
Pesch B; Ko Y; Brauch H; Hamann U; Harth V; Rabstein S; Pierl C; Fischer HP; Baisch C; Justenhoven C; Ranft U; Brüning T
Eur J Epidemiol; 2005; 20(8):699-711. PubMed ID: 16151884
[TBL] [Abstract][Full Text] [Related]
37. Hormone replacement therapy regimens and breast cancer risk(1).
Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
[TBL] [Abstract][Full Text] [Related]
38. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
39. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
40. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
MacDougall LA; Barzilay JI; Helmick CG
J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
